Correlation Between Pluri and Purple Biotech

Can any of the company-specific risk be diversified away by investing in both Pluri and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pluri Inc and Purple Biotech, you can compare the effects of market volatilities on Pluri and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and Purple Biotech.

Diversification Opportunities for Pluri and Purple Biotech

0.32

Correlation Coefficient

Pluri  Purple Biotech

Weak diversification

The 3 months correlation between Pluri and Purple is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Pluri i.e., Pluri and Purple Biotech go up and down completely randomly.

Pair Corralation between Pluri and Purple Biotech

Given the investment horizon of 90 days Pluri Inc is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Pluri Inc is 4.19 times less risky than Purple Biotech. The stock trades about 0.0 of its potential returns per unit of risk. The Purple Biotech is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  802.00  in Purple Biotech on September 14, 2024 and sell it today you would lose (436.00) from holding Purple Biotech or give up 54.36% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pluri Inc  vs.  Purple Biotech

Pluri Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Purple Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively weak fundamental drivers, Purple Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Pluri and Purple Biotech

The main advantage of trading using opposite Pluri and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.

The idea behind Pluri Inc and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.